Price Transparency Isn't Optional - It's a Financial Imperative for Health Systems

Patients expect clear, upfront pricing — and regulators increasingly require it. Yet siloed systems and inconsistent data still make transparency a challenge for hospitals and health systems. 

For CFOs and financial operations leaders, transparency has become a strategic lever for strengthening patient trust, improving financial performance, and reducing operational friction. It also supports broader affordability initiatives — including pharmacy programs like 340B — that can help protect margin as costs rise.

In this Becker’s Hospital Review webinar, leaders from Prisma Health, the National Council for Prescription Drug Programs, and DialCare share how transparency is evolving and what financially minded organizations are doing to stay ahead. 

What you'll learn:

  • How clearer cost communication builds trust and improves financial outcomes 
  • Strategies to integrate real-time cost data into provider workflows and patient channels 
  • Common implementation challenges — and how leading organizations overcome them 
  • How transparency supports interoperability, compliance, and better patient experiences 
  • How affordability tools and programs like 340B enhance financial performance 

Financial Impact by the Numbers (DoseSpot Data)

  • Large health systems see an estimated $10M in net new annual margin contribution from improved prescription capture and affordability workflows. 
  • DoseSpot Connect users achieve an average 12% increase in 340B-eligible script capture, strengthening pharmacy-related margin. 
  • GLP-1 affordability impact: Nearly $300K in monthly patient savings, with $100 saved per prescription, totaling $1M in 3-month savings and $15M in projected annual refill savings.  
Watch the Webinar On-Demand
Fill out the form to learn how transparency, affordability, and smarter financial workflows are shaping the future of health system performance.

Featured Speakers:

Screenshot 2025-12-02 at 2.54.46 PM